CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway

Prostate cancer (PCa) endangers the life and health of older men. Most PCa cases develop into castration-resistant PCa (CRPC) within 2 years. At present, the molecular mechanisms of the occurrence and development of PCa and its transformation to CRPC remain unknown. The present study aimed to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linjin, Hu, Yiren, Chen, Dake, Zhu, Jianlong, Bao, Wenshuo, Xu, Xiaomin, Chen, Heyi, Chen, Wu, Feng, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628290/
https://www.ncbi.nlm.nih.gov/pubmed/34791506
http://dx.doi.org/10.3892/mmr.2021.12533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628290/
https://www.ncbi.nlm.nih.gov/pubmed/34791506
http://dx.doi.org/10.3892/mmr.2021.12533

Ejemplares similares